<DOC>
	<DOCNO>NCT00689975</DOCNO>
	<brief_summary>RATIONALE : Studying diet exercise intervention overweight obese patient breast cancer may help doctor learn help patient lose weight change body composition . PURPOSE : This randomized clinical trial study diet exercise see well works compare normal care overweight obese woman undergone treatment stage I , stage II , stage III breast cancer .</brief_summary>
	<brief_title>Diet Exercise Normal Care Overweight Obese Women Who Have Undergone Treatment Stage I , Stage II , Stage III Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - To examine effect dietary exercise intervention body weight body composition overweight obese woman undergone breast cancer treatment . - To examine effect dietary exercise intervention index psychological health status biomarkers associate disease recurrence overweight obese woman undergone breast cancer treatment . Secondary - To examine relationship change body weight biomarkers associated disease recurrence physiological health status , include circulating level estrogen , C-reactive protein , interleukin-6 . - To examine relationship change psychological health status , circulate stress hormone , index immune function . - To examine effect dietary exercise intervention broad quality-of-life dimension . OUTLINE : Patients randomize one intervention arm . - Arm I ( lifestyle intervention ) : Patients undergo moderate-intensity aerobic-exercise session 3 5 day week 24 week . Patients able attend five supervised session counsel fit extra 1-2 home/community-based exercise session weekly routine . All session physical activity record physical activity log . Portable pedometer use determine number steps/distance walk day . Patients wear heart-rate monitor throughout exercise session . Heart rate rating perceive exertion assess regular interval . The exercise-therapy session use variety cognitive-behavioral technique promote exercise adherence well positive attitude experience . Patients also give individualized healthy-eating dietary advice write information packet name ' Weight Loss On A Plate ' . Patients also counsel reduce dietary fat intake 25 % total caloric intake , eat least 5 portion fruit vegetable daily , increase fiber intake , reduce carbohydrate , take moderate amount alcohol . Patients also counsel reduce total daily calorie intake 600 kcal calculate energy requirement . Individual energy requirement estimate formula basal metabolic rate physical activity level . Patients complete 3-day diet diary prior begin study treatment weekly throughout study . The diary pre-intervention week 6 , 12 , 18 , 24 analyze , look specifically macronutrients . Patients meet research assistant weekly discus individual diet diary identify way improve nutritional intake . - Arm II ( normal care ) : Patients provide general healthy-eating booklet entitle , `` Getting Balance Right '' . Depression , psychological stress , quality life assess baseline 12 week , 25 week . Blood sample examine various biomarkers include interleukin-6 ELISA , estradiol radioimmunoassay , lymphocyte phenotyping NK-cell activity flow cytometry . Salivary cortisol level measure 4 time two consecutive day high-sensitivity salivary cortisol enzyme immunoassay .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis stage I , II , III breast cancer No metastatic breast cancer No inoperable active locoregional disease Body mass index ( BMI ) &gt; 25 Patients must complete treatment breast cancer within past 318 month Hormone receptor status specify PATIENT CHARACTERISTICS : Female Menopausal status specify Willing able attend supervise exercise session least 3 time per week period 24 week Patients must exercise precontemplator , contemplator , preparer define transtheoretical model No physical/psychiatric impairment would seriously impair physical mobility No severe nausea , anorexia , diseases affect health ( e.g. , arthritis multiple sclerosis ) More 3 month since prior exercise currently engage exercise ( two time per week least 30 minute per session ) PRIOR CONCURRENT THERAPY : See Disease Characteristics Concurrent tamoxifen , endocrine treatment , trastuzumab ( HerceptinÂ® ) allow No concurrent alternative/complementary diet No concurrent highdose antioxidant supplement therapy More 4 month since prior concurrent hormonereplacement therapy oral contraceptive</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>stage IA breast cancer</keyword>
	<keyword>stage IB breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>stage IIIC breast cancer</keyword>
</DOC>